ONLINE DATABASE SEARCH - DMID-LS-75-MEMO
1. 6375 DMID-LS-75; WOS-DMID-9/14/2004
Synthesis of Biln 2061, an Hcvns3 Protease Inhibitor With Proven Antiviral Effect in Humans
Faucher, A. et al.
Organic Letters 2004. 6(17): 2901-2904
2. 6376 DMID-LS-75; SCIFINDER-DMID-9/14/2004
Fatal disseminated mouse adenovirus type 1 infection in mice lacking B cells or Bruton's tyrosine kinase
Moore, Martin L, McKissic, Erin L, Brown, Corrie C, Wilkinson, John E, and Spindler, Katherine R
Journal of Virology 2004. 78(11): 5584-5590
3. 6377 DMID-LS-75; WOS-DMID-9/14/2004
A Phase I/Ii Dose Escalation Trial Assessing Tolerance, Pharmacokinetics, and Antiviral Activity of Nm283, a Novel Antiviral Treatment for Hepatitis C
Godofsky, E. et al.
Gastroenterology 2004. 126(4): A681
4. 6378 DMID-LS-75; PUBMED-DMID-9/14/2004
Evaluation of sulfated fungal beta-glucans from the sclerotium of Pleurotus tuber-regium as a potential water-soluble anti-viral agent
Zhang, M, Cheung, PC, Ooi, VE, and Zhang, L
Carbohydr Res 2004. 339(13): 2297-301
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15337458&dopt=abstract
5. 6379 DMID-LS-75; WOS-DMID-9/14/2004
Pegylated Interferon (Alpha-2b) and Ribavirin (Rebetol) for the Treatment of Hcv Infected Patients Who Failed Prior Therapy: Sustained Response Data
Gaglio, P. et al.
Gastroenterology 2004. 126(4): A721
6. 6380 DMID-LS-75; WOS-DMID-9/14/2004
Antiviral Properties of Pegylated Versus Non-Pegylated Interferon Alpha-2b Against Hepatitis C in Cell Culture
Joshi, V. et al.
Gastroenterology 2004. 126(4): A760
7. 6381 DMID-LS-75; PUBMED-DMID-9/14/2004
Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine
Cooper, CL, Davis, HL, Morris, ML, Efler, SM, Krieg, AM, Li, Y, Laframboise, C, Al, Adhami MJ, Khaliq, Y, Seguin, I, and Cameron, DW
Vaccine 2004. 22(23-24): 3136-43
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15297066&dopt=abstract
8. 6382 DMID-LS-75; WOS-DMID-9/14/2004
Sulfated Seaweed Polysaccharides as Antiviral Agents
Damonte, E., Matulewicz, M., and Cerezo, A.
Current Medicinal Chemistry 2004. 11(18): 2399-2419
9. 6383 DMID-LS-75; WOS-DMID-9/14/2004
Synthesis of N-1-Alkylated 6-Benzyluracil-5-Carboxylic Esters as Potential Non-Nucleoside Reverse Transcriptase Inhibitors
Larsen, J., Pedersen, E., and Nielsen, C.
Synthesis-Stuttgart 2004.(11): 1874-1878
10. 6384 DMID-LS-75; WOS-DMID-9/14/2004
Peroxynitrite Inhibition of Coxsackievirus Infection by Prevention of Viral Rna Entry
Padalko, E. et al.
Proceedings of the National Academy of Sciences of the United States of America 2004. 101(32): 11731-11736
11. 6385 DMID-LS-75; PUBMED-DMID-9/14/2004
Human Cytomegalovirus UL76 Encodes a Novel Virion-Associated Protein That Is Able To Inhibit Viral Replication
Wang, SK, Duh, CY, and Wu, CW
J Virol 2004. 78(18): 9750-62
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15331708&dopt=abstract
12. 6386 DMID-LS-75; WOS-DMID-9/14/2004
Anticancer and Antiviral Activities of Youngia Japonica (L.) Dc (Asteraceae, Compositae)
Ooi, L. et al.
Journal of Ethnopharmacology 2004. 94(1): 117-122
13. 6387 DMID-LS-75; WOS-DMID-9/14/2004
New Antivirals and Antiviral Resistance
Prober, CG 549: 9-12
14. 6388 DMID-LS-75; SCIFINDER-DMID-9/14/2004
<04 Article Title>
Neumann, Gabriele, Noda, Takeshi, Takada, Ayato, Jasenosky, Luke D, and Kawaoka, Yoshihiro
<10 Journal Title> 2004.(<24 Issue ID>): <25 Page(s)>
15. 6389 DMID-LS-75; SCIFINDER-DMID-9/14/2004
Preparation of thiophenecarboxylates for the treatment or prevention of flavivirus infections
Chan Chun Kong, Laval, Das, Sanjoy Kumar, Nguyen-Ba, Nghe, Halab, Liliane, Hamelin, Bettina, Pereira, Oswy Z, Poisson, Carl, Proulx, Melanie, Reddy, Thumkunta Jagadeeswar, and Zhang, Ming-qiang
PATENT: WO 2004052885 ISSUE DATE: 20040624
APPLICATION: 2003 PP: 192 pp.
ASSIGNEE: (Virochem Pharma Inc., Can.
16. 6390 DMID-LS-75; SCIFINDER-DMID-9/14/2004
Treatment of Flaviviridae infection with 2'-branched nucleosides and another mutation-inducing drug such as interferon
Sommadossi, Jean-Pierre, La Colla, Paolo, Standring, David, Bichko, Vadim, and Qu, Lin
PATENT: WO 2004046331 ISSUE DATE: 20040603
APPLICATION: 2003 PP: 166 pp.
ASSIGNEE: (Idenix (Cayman) Limited, Cayman I. and Universita Degli Studi Di Cagliari)
17. 6391 DMID-LS-75; WOS-DMID-9/14/2004
Evaluation of Scopadulciol-Related Molecules for Their Stimulatory Effect on the Cytotoxicity of Acyclovir and Ganciclovir Against Herpes Simplex Virus Type 1 Thymidine Kinase Gene-Transfected Hela Cells
Hayashi, K. et al.
Chemical & Pharmaceutical Bulletin 2004. 52(8): 1015-1017
18. 6392 DMID-LS-75; SCIFINDER-DMID-9/14/2004
Agents with leukotriene B4-like antiviral (DNA) and anti-neoplastic activities
Gosselin, Jean and Borgeat, Pierre
PATENT: US 2004132820 ISSUE DATE: 20040708
APPLICATION: 2003-28522 PP: 26 pp., Cont.-in-part of U.S. Ser. No. 548,187, abandoned.
ASSIGNEE: (Can.)
19. 6393 DMID-LS-75; SCIFINDER-DMID-9/14/2004
Process for preparation of pyrrolylquinones and indolylquinones and their use for treating neurodegenerative disease, viral infections and proliferative disease
Pirrung, Michael C and Rudolph, Johannes
PATENT: US 2004063774 ISSUE DATE: 20040401
APPLICATION: 2002-59289 PP: 25 pp.
ASSIGNEE: (USA)
20. 6394 DMID-LS-75; WOS-DMID-9/14/2004
Using Antiviral Drugs for Orthopoxvirus Infections
Snoeck, R., De Clercq, E., and Andrei, G.
Medecine Et Maladies Infectieuses 2004. 34: S48-S50
21. 6395 DMID-LS-75; SCIFINDER-DMID-9/14/2004
Synthesis and structure-activity relationships of the halovirs, antiviral natural products from a marine-derived fungus
Rowley, David C, Kelly, Sara, Jensen, Paul, and Fenical, William
Bioorganic & Medicinal Chemistry 2004. 12(18): 4929-4936
22. 6396 DMID-LS-75; SCIFINDER-DMID-9/14/2004
Metabolites produced by actinomycetes. Antiviral antibiotics and enzyme inhibitors
Uyeda, Masaru
Yakugaku Zasshi 2004. 124(8): 469-480
23. 6397 DMID-LS-75; SCIFINDER-DMID-9/14/2004
Antiviral effects of aciclovir injectable formulation (Acirovec and Zovirax for i.v. infusion) against herpes simplex virus type 1 in vitro and in vivo
Ogura, Takeharu, Ohtsubo, Yoshikazu, Ueda, Haruyasu, and Okamura, Haruki
Japanese Pharmacology & Therapeutics 2004. 32(6): 349-352
24. 6398 DMID-LS-75; SCIFINDER-DMID-9/14/2004
Anti-viral activity of norfloxacin and ampicillin and dibutyltin polymers derived from norfloxacin and ampicillin against reovirus ST3, vaccinia virus, herpes simplex virus (HSV-1) and varicella zoster
Roner, Michael R, Carraher, Charles E Jr, Roehr, Joanne L, Bassett, Kelly D, and Siegmann-Louda, Deborah W
Polymeric Materials: Science and Engineering 2004. 91: 744-746
25. 6399 DMID-LS-75; SCIFINDER-DMID-9/14/2004
Preparation of isoxazole-containing thiourea inhibitors useful for treatment of varicella zoster virus
Bloom, Jonathan David
PATENT: US 2004157900 ISSUE DATE: 20040812
APPLICATION: 2004-51903 PP: 9 pp.
ASSIGNEE: (Wyeth Holdings Corporation, USA
26. 6400 DMID-LS-75; SCIFINDER-DMID-9/14/2004
A preparation of thieno[3,2-b]pyridinecarboxamide derivatives, useful as antiviral agents
Larsen, Scott D, May, Paul, Romines, Karen, Schnute, Mark E, and Tanis, Steven P
PATENT: US 2004138449 ISSUE DATE: 20040715
APPLICATION: 2003-17415 PP: 35 pp.
ASSIGNEE: (USA)
27. 6401 DMID-LS-75; SCIFINDER-DMID-9/14/2004
Methods and compositions for the treatment of herpes virus infections using cyclooxygenase-2 selective inhibitors or cyclooxygenase-2 inhibitors in combination with antiviral agents
Maziasz, Timothy
PATENT: WO 2004056349 ISSUE DATE: 20040708
APPLICATION: 2003 PP: 155 pp.
ASSIGNEE: (Pharmacia Corporation, USA
28. 6402 DMID-LS-75; SCIFINDER-DMID-9/14/2004
Antimicrobial activity of antibodies producing reactive oxygen species
Wentworth, Paul and Lerner, Richard A
PATENT: WO 2004044191 ISSUE DATE: 20040527
APPLICATION: 2003 PP: 131 pp.
ASSIGNEE: (Novartis A.-G., Switz., Novartis Pharma G.m.b.H., and The Scripps Research Institute)
29. 6403 DMID-LS-75; SCIFINDER-DMID-9/14/2004
Antiviral oligonucleotides targeting HBV
Vaillant, Andrew and Juteau, Jean-Marc
PATENT: US 20040162253 ISSUE DATE: 20040819
APPLICATION: 2003-5728 PP: 84 pp., Cont.-in-part of WO 2004 24,919.
ASSIGNEE: (Replicor, Inc. Can.
30. 6404 DMID-LS-75; SCIFINDER-DMID-9/14/2004
Antiviral oligonucleotides targeting HSV and CMV
Vaillant, Andrew and Juteau, Jean-Marc
PATENT: US 20040162254 ISSUE DATE: 20040819
APPLICATION: 2003-5737 PP: 84 pp., Cont.-in-part of WO 2004 24,919.
ASSIGNEE: (Replicor, Inc. Can.
31. 6405 DMID-LS-75; SCIFINDER-DMID-9/14/2004
Mechanisms of Host Defense following Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) Pulmonary Infection of Mice
Glass, William G, Subbarao, Kanta, Murphy, Brian, and Murphy, Philip M
Journal of Immunology 2004. 173(6): 4030-4039
32. 6406 DMID-LS-75; SCIFINDER-DMID-9/14/2004
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine
Keyaerts, Els, Vijgen, Leen, Maes, Piet, Neyts, Johan, and Van Ranst, Marc
Biochemical and Biophysical Research Communications 2004. 323(1): 264-268
33. 6407 DMID-LS-75; SCIFINDER-DMID-9/14/2004
Antiviral medicament and method for producing and using the same for the prophylactic and therapeutic treatment of papillomavirus induced tumors, lesions and deseases
Albahri, Tareq Abduljalil
PATENT: US 2004109899 ISSUE DATE: 20040610
APPLICATION: 2002-53302 PP: 23 pp.
ASSIGNEE: (Kuwait)
34. 6408 DMID-LS-75; SCIFINDER-DMID-9/14/2004
Pathogen-host standoff Immunity to polyomavirus infection and neoplasia
Lukacher, Aron E
Immunologic Research 2004. 29(1-3): 139-150